12 對 29 名
耐藥性抑鬱患者進行雙盲、隨機安慰劑對照試驗 DMT 臨牀證據:DMT 在 TRD 中的隨機對照試驗的療效先前的臨牀證據(第三方 STUDY1)雙盲、隨機安慰劑對照試驗 Ayahuasca(DMT 是主要活性成分)
對 29 名患者 TRD 安慰劑 N, N-DMT P<.0001 score trd="Treatment" resistant depression dmt="N,N-Dimethyltryptamine 1." palhano-fontes et al. antidepressant e of the psychedelic ayahuasca in treatment-resistant psychol med a single administration .36 mg met both primary and key secondary efficacy endpoints by demonstrating rapid statistically significant changes on severity measures ham-d madrs endpoint not shown n arm achieved difference relative to placebo were no serious adverse events reported. see left differences observed at all timepoints assessed including as early day through is potential registrational endpoint. takeaways>